Thyrocare Technologies announces dividend
Avalokita Pandey / 30 Jan 2017

For the financial year 2016-17, Thyrocare Technologies Limited has announced to pay an interim dividend of Rs 5 per share (fixed) as the board of directors has approved the unaudited financial statements, both standalone and consolidated, for the quarter or nine months, which ended on December 31, 2016.
For the financial year 2016-17, Thyrocare Technologies Limited has announced to pay an interim dividend of Rs 5 per share (fixed) as the board of directors has approved the unaudited financial statements, both standalone and consolidated, for the quarter or nine months, which ended on December 31, 2016.
The financial results for the quarter or nine month ended on December 31, 2016, along with the limited review reports published separately to the exchanges pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
Thyrocare Technologies Ltd. is the India's first fully-automated diagnostic laboratory, which lays an emphasis on providing quality at reasonable costs to hospital labs in India and other countries. It is looked upon as a yardstick for quality by stakeholders in the diagnostic industry. The uniqueness of Thyrocare Technologies Ltd. is its effort to innovate and remain at par of the global standards for best quality service delivery and for its cost-effective prices.